Search results for "Kiev"

showing 10 items of 44 documents

Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice

2014

Coxsackievirus B3 (CVB3) is an important cause of acute and chronic viral myocarditis, and dilated cardiomyopathy (DCM). Although vaccination against CVB3 could significantly reduce the incidence of serious or fatal viral myocarditis and various other diseases associated with CVB3 infection, there is currently no vaccine or therapeutic reagent in clinical use. In this study, we contributed towards the development of a CVB3 vaccine by establishing an efficient and scalable ion exchange chromatography-based purification method for CVB3 virus and baculovirus-insect cell-expressed CVB3 virus-like particles (VLPs). This purification system is especially relevant for vaccine development and produ…

Viral MyocarditisvirusesIon chromatographyGenetic VectorsCoxsackievirus InfectionsBiologyAntibodies ViralVirus03 medical and health sciencesMice0302 clinical medicineImmune systemVirus-like particleAntibody SpecificityVirologyGene OrderAnimalscardiovascular diseases030212 general & internal medicineVaccines Virus-Like Particle030304 developmental biologyPharmacology0303 health sciencesImmunity Cellularta1182virus diseasesmusculoskeletal systemChromatography Ion ExchangeVirology3. Good healthEnterovirus B HumanVaccinationDisease Models AnimalImmunizationCoxsackievirus b3cardiovascular systemFemaleImmunizationBaculoviridaeAntiviral Research
researchProduct

Blanche de Castille

2009

[SHS.DROIT]Humanities and Social Sciences/Law[SHS.DROIT] Humanities and Social Sciences/Lawmonarchieduchesse de BerryrégentesBlanche de CastilleAnne de Kiev[ SHS.DROIT ] Humanities and Social Sciences/Lawfemmes de pouvoir
researchProduct

Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine

2020

Coxsackievirus B (CVB) enteroviruses are common pathogens that can cause acute and chronic myocarditis, dilated cardiomyopathy, aseptic meningitis, and they are hypothesized to be a causal factor in type 1 diabetes. The licensed enterovirus vaccines and those currently in clinical development are traditional inactivated or live attenuated vaccines. Even though these vaccines work well in the prevention of enterovirus diseases, new vaccine technologies, like virus-like particles (VLPs), can offer important advantages in the manufacturing and epitope engineering. We have previously produced VLPs for CVB3 and CVB1 in insect cells. Here, we describe the production of CVB3-VLPs with enhanced pro…

and promotion of well-beingvirusesPROTECTS MICEPOLIOVIRUSCardiovascularcomplex mixturesvirus-like particle (VLP)virus-like particleVaccine RelatedvaccineIMMUNE-RESPONSECoxsackievirus B (CVB)COXSACKIEVIRUS B3lcsh:QH301-705.5PARTICLE VACCINE11832 Microbiology and virologyPreventionrokotteetvirus diseasesMICROSCOPYPrevention of disease and conditionsenteroviruksetHeart DiseaseInfectious DiseasesGood Health and Well Beinglcsh:Biology (General)3.4 VaccinesCoxsackievirus BENTEROVIRUS 71VIRUSImmunization3111 BiomedicineInfectionRECEPTOR-BINDINGB1Biotechnology
researchProduct

Organizacja obchodów 1025 rocznicy Chrztu Rusi Kijowskiej jako przykład szczególnych relacji Państwo-Kościół na Ukrainie

2018

church-state relationsreligious organizationsUkraineBaptism of Kievan RusPrzegląd Prawa Wyznaniowego
researchProduct

Infectious Entry Pathway of Enterovirus B Species

2015

Enterovirus B species (EV-B) are responsible for a vast number of mild and serious acute infections. They are also suspected of remaining in the body, where they cause persistent infections contributing to chronic diseases such as type I diabetes. Recent studies of the infectious entry pathway of these viruses revealed remarkable similarities, including non-clathrin entry of large endosomes originating from the plasma membrane invaginations. Many cellular factors regulating the efficient entry have recently been associated with macropinocytic uptake, such as Rac1, serine/threonine p21-activated kinase (Pak1), actin, Na/H exchanger, phospholipace C (PLC) and protein kinase Cα (PKCα). Another…

coxsackievirus A9EchovirusEndosomelcsh:QR1-502Virus AttachmentEndosomesReviewCoxsackievirusEndocytosismedicine.disease_causelcsh:Microbiology03 medical and health sciencesVirologymedicineReceptorProtein kinase A030304 developmental biology0303 health sciencesbiologyKinase030302 biochemistry & molecular biologyechovirusVirus Internalizationbiology.organism_classificationVirologyEndocytosisEnterovirus B Human3. Good healthCell biologyInfectious DiseasesHost-Pathogen InteractionsEnterovirusentrycoxsackievirus B3signalingViruses
researchProduct

Enterovirus-induced non-acidic entry pathway and its relation to the epidermal growth factor receptor pathway

2014

coxsackievirus A9echovirus 1enteroviruksetviruksetEGFRendocytosisendosomitECHO-viruksetepidermaalisen kasvutekijän reseptoriepidermal growth factor receptorendosytoosimultivesicular bodysolubiologia
researchProduct

Infectious Entry Pathway of Enterovirus B Species

2015

coxsackievirus A9ta1183echovirusta1182entrycoxsackievirus B3signalingViruses
researchProduct

Unveiling adaptive mechanisms though experimental evolution: the role of duplicated genes and phenotypic plasticity in yeast, and the genetic variabi…

2021

Los seres vivos se enfrentan a condiciones ambientales cambiantes y habitualmente estresantes, agravadas por el cambio climático, que ponen a prueba su capacidad de supervivencia. El cambio en la composición genética de las poblaciones reside en las mutaciones, que son la fuente para la evolución y la adaptación a los cambios. La diversidad genética intrapoblacional está regulada por dos grandes fuerzas evolutivas que cambian la composición genética permitiendo así el acceso a nuevos fenotipos: la deriva genética y la selección natural. Por un lado, la deriva genética fija mutaciones en la población de manera aleatoria e independiente del efecto que suponga dicha mutación para la población.…

coxsackievirusDMSevolutiongene duplicationUNESCO::CIENCIAS DE LA VIDAS.cerevisiaeadaptationphenotypic plasticity:CIENCIAS DE LA VIDA [UNESCO]
researchProduct

Transmisión colectiva de enterovirus asociada a membranas: Bases genéticas e implicaciones evolutivas

2021

Los virus son responsables de numerosas enfermedades. Muchas de éstas son crónicas y se estima que el 20% de los cánceres son causados por infecciones virales. Además, gracias a su gran capacidad adaptativa y a su facilidad de transmisión, tienen cierta facilidad para saltar de una especie a otra, por lo que muchos virus que infectan animales son potenciales zoonosis confiriéndoles un considerable potencial pandémico. Estudiar y comprender mejor a los virus es un paso esencial en la elaboración de mejores protocolos de salud y epidemiología, así como en la búsqueda de nuevos fármacos antivirales. En los últimos años se ha descubierto que los virus pueden transmitirse en grupo de un huésped …

coxsackievirusUNESCO::CIENCIAS DE LA VIDA::Genética:CIENCIAS DE LA VIDA::Genética [UNESCO]enterovirusvirusestransmisión colectivaevolución experimentaltransmisión viral
researchProduct

Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine

2019

Type B Coxsackieviruses (CVBs) are a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. We have previously produced virus-like particles (VLPs) for CVB3 with a baculovirus-insect cell production system. Here we have explored the potential of a VLP-based vaccine targeting CVB1 and describe the production of CVB1-VLPs with a scalable VLP purification method. The developed purification method consisting of tangential flow filtration and ion exchange chromatography is compatible with industrial scale production. CVB1-VLP vaccine was treated with UV-C or formalin to study whether stability and immuno…

enteroviruksetBiolääketieteet - BiomedicinevirusesvaccinerokotteetCoxsackievirus Bvirus diseasesformaldehydicomplex mixturesformalinvirus-like particle
researchProduct